| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KLAC | Common Stock | Sale | $5,074,810 | -14,854 | -15% | $341.65 | 83,130 | 10 Aug 2021 | Direct | F1, F2 |
| transaction | KLAC | Common Stock | Sale | $1,851,200 | -5,404 | -6.5% | $342.56 | 77,726 | 10 Aug 2021 | Direct | F1, F3 |
| transaction | KLAC | Common Stock | Sale | $2,368,430 | -6,897 | -8.9% | $343.40 | 70,829 | 10 Aug 2021 | Direct | F1, F4 |
| transaction | KLAC | Common Stock | Sale | $2,230,008 | -6,474 | -9.1% | $344.46 | 64,355 | 10 Aug 2021 | Direct | F1, F5 |
| transaction | KLAC | Common Stock | Sale | $403,075 | -1,166 | -1.8% | $345.69 | 63,189 | 10 Aug 2021 | Direct | F1, F6 |
| transaction | KLAC | Common Stock | Sale | $277,019 | -800 | -1.3% | $346.27 | 62,389 | 10 Aug 2021 | Direct | F1, F7 |
| transaction | KLAC | Common Stock | Sale | $794,304 | -2,284 | -3.7% | $347.77 | 60,105 | 10 Aug 2021 | Direct | F1, F8 |
| transaction | KLAC | Common Stock | Sale | $701,300 | -2,011 | -3.3% | $348.73 | 58,094 | 10 Aug 2021 | Direct | F1, F9 |
| transaction | KLAC | Common Stock | Sale | $559,259 | -1,600 | -2.8% | $349.54 | 56,494 | 10 Aug 2021 | Direct | F1, F10 |
| transaction | KLAC | Common Stock | Sale | $105,357 | -300 | -0.53% | $351.19 | 56,194 | 10 Aug 2021 | Direct | F1, F11 |
| holding | KLAC | Common Stock - Restricted Stock Units | 195,502 | 10 Aug 2021 | Direct | F12, F13 | |||||
| holding | KLAC | Common Stock | 9,182 | 10 Aug 2021 | By Trust | F14 |
| Id | Content |
|---|---|
| F1 | This sale was effected pursuant to the terms of a Rule 10b5-1 trading plan adopted by the Reporting Person on February 23, 2021. |
| F2 | Represents the weighted average sales price for the shares. The sales prices ranged from $340.98 to $341.97. The reporting person will provide upon request full information regarding the number of shares sold at each separate price. |
| F3 | Represents the weighted average sales price for the shares. The sales prices ranged from $342.00 to $342.79. The reporting person will provide upon request full information regarding the number of shares sold at each separate price. |
| F4 | Represents the weighted average sales price for the shares. The sales prices ranged from $343.01 to $343.94. The reporting person will provide upon request full information regarding the number of shares sold at each separate price. |
| F5 | Represents the weighted average sales price for the shares. The sales prices ranged from $344.06 to $344.98. The reporting person will provide upon request full information regarding the number of shares sold at each separate price. |
| F6 | Represents the weighted average sales price for the shares. The sales prices ranged from $345.10 to $346.06. The reporting person will provide upon request full information regarding the number of shares sold at each separate price. |
| F7 | Represents the weighted average sales price for the shares. The sales prices ranged from $346.14 to $346.67. The reporting person will provide upon request full information regarding the number of shares sold at each separate price. |
| F8 | Represents the weighted average sales price for the shares. The sales prices ranged from $347.26 to $348.25. The reporting person will provide upon request full information regarding the number of shares sold at each separate price. |
| F9 | Represents the weighted average sales price for the shares. The sales prices ranged from $348.26 to $349.21. The reporting person will provide upon request full information regarding the number of shares sold at each separate price. |
| F10 | Represents the weighted average sales price for the shares. The sales prices ranged from $349.27 to $349.98. The reporting person will provide upon request full information regarding the number of shares sold at each separate price. |
| F11 | Represents the weighted average sales price for the shares. The sales prices ranged from $350.86 to $351.71. The reporting person will provide upon request full information regarding the number of shares sold at each separate price. |
| F12 | Each RSU represents a contingent right to receive one share of KLA common stock. |
| F13 | Does not include performance-based RSUs, if any, held by the Reporting Person for which an assessment has not yet been made regarding the achievement of the applicable performance goals. Any such holdings will be reported on a Form 4 within two business days of the date such assessment is made. |
| F14 | Shares held under the Wallace Living Trust u/a/d 03/27/01, as amended, a trust of which the Reporting Person is a trustee and beneficiary. |